STD Testing Devices Market accounted for USD 70.29 Billion and is expected to register a CAGR of 9.3% during the forecast period.
The growth of the global STD testing devices market is driven by various factors such as an increase in the prevalence of sexually transmitted diseases, increasing prevalence of lifestyle diseases, and increasing mergers & acquisitions by prominent players in the market. However, lack of knowledge about the symptoms is projected to hamper the growth of the global STD testing devices market.
The Global STD Testing Devices Market is currently dominated by several market players. Additionally, growing initiatives to create awareness is driving the growth of the market. For instance, Inovio Pharmaceuticals, Inc. in 2018, signed an agreement with ApolloBio Corp. for the exclusive rights for the development, manufacturing, and commercialization of VGX – 3100, Inovio’s DNA immunotherapy product. This product is used for pre-cancer indication.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8582
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The STD testing devices market in the Americas has further been branched into North America and Latin America, with the North American market is divided into the US and Canada. The European STD testing devices market has been categorized into Western Europe and Eastern Europe. The Western European market has further been classified into Germany, France, UK, Italy, Spain, and the rest of Western Europe. The STD testing devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of sexually transmitted diseases and increasing patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The STD testing devices market in the Middle East & Africa has been bifurcated into the Middle East and Africa.
Segmentation
The Global STD Testing Devices Market has been segmented based on type and end-user.
The market, based on type, has been divided into laboratory devices and point of care (POC) devices. The laboratory devices segment is expected to be the largest. The laboratory devices are further segmented into thermal cyclers, cellulose-based devices, flow cytometers, enzyme-linked immunosorbent assay (ELISA) and others. The point of care devices is segmented into phone chips, rapid diagnostic kits, and others.
In terms of end-user, the global STD testing devices market has been segmented into hospitals and clinics diagnostic laboratories and research laboratories and institutes. Hospitals and clinics take up the largest share. The hospital's segment is expected to hold the largest share of the market, as these are the primary locations where patients receive treatment.
Key Players
Some of the Key Players in the Global STD Testing Devices Market are Abbott (US), Meridian Bioscience (US), Thermo Fisher Scientific (US), MedMira Inc. (Canada), F. Hoffmann-La Roche AG (Switzerland), Bio-Rad Laboratories, Inc. (US), Diasorin S.p.A (Italy), Becton Dickinson and Company (US), Hologic, Inc. (US), Cepheid (Danaher Corporation) (US), bioMeriuex (France), Qaigen Inc. (US), OraSure Technologies (US), GenePOC Inc. (Canada).
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/std-testing-devices-market-8582
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Email: [email protected]
Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
[270 Pages Report] The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period.The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.
However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market’s growth to a certain extent.Market DynamicsHigh prevalence of infectious diseases in womenRising incidence of chronic and lifestyle-related disorders in womenIncreasing awareness about fertility testing in women and initiatives by government and health organizationsIncreased adoption of POC and rapid diagnostic testsGrowth in the number of private diagnostic and imaging centersPublic-private partnerships are expected to enhance infrastructure in diagnostic imaging centersBased on application, the women’s health diagnostics market is divided into nine segments—osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.
The large share of this segment can be attributed to the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as ABUSDownload PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901COVID-19 Impact on Global Women’s Health Diagnostics MarketSince the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.
This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.
Additionally, we are estimating that the major share of the medical devices industry that includes imaging devices, and surgical products among others, which contribute 60-75% of the overall medical devices market will have a stagnant or deep fall in the growth rate in 2020 and couple of quartered from 2021.
Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market’s growth to a certain extent.Market DynamicsHigh prevalence of infectious diseases in womenRising incidence of chronic and lifestyle-related disorders in womenIncreasing awareness about fertility testing in women and initiatives by government and health organizationsIncreased adoption of POC and rapid diagnostic testsGrowth in the number of private diagnostic and imaging centersPublic-private partnerships are expected to enhance infrastructure in diagnostic imaging centersBased on application, the women’s health diagnostics market is divided into nine segments—osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.
The large share of this segment can be attributed to the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as ABUSGet a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901COVID-19 Impact on Global Women’s Health Diagnostics MarketSince the beginning of 2020, more and more countries across the globe shut down their borders and limited transportation and travel to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation.
This had disrupted the supply chains for the women’s health diagnostics market, temporarily leading to fall in demand due to uncertainty in the global economy and capital markets.
Additionally, we are estimating that the major share of the medical devices industry that includes imaging devices, and surgical products among others, which contribute 60-75% of the overall medical devices market will have a stagnant or deep fall in the growth rate in 2020 and couple of quartered from 2021.
A new, USD 5-7 billion market opportunity (by 2021) is opening up in the medical devices industry that includes critical care medical devices.In 2019, North America accounted for the largest share of the women’s health diagnostics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
